• Webinar Details

  • Home / Learn / Live CE / Live CE Event Calendar / Webinar Details


Reducing Cardiovascular Events in Patients with T2D

Event Type

Live Online

Date

Wednesday, March 13, 2019

Time

10:30 AM - 12:30 PM ET

Location

PharmCon Webinar Studio (freeCE.com)

Credits

2 Contact Hour(s)

Target Audience

Nurse, Pharmacist

Cost

$0.00

  • Overview

    Patients with diabetes are much more likely to suffer from cardiovascular disease than those without diabetes. In fact, cardiovascular disease is the leading cause of death associated with diabetes. Findings from several recent clinical trials highlight the limitations of focusing exclusively on glycemic treatment goals for type 2 diabetes (T2D) and emphasize the need for cardiovascular risk reduction as well. Pharmacists are often the medical professional that patients reach out to for guidance and explanation on new pharmacotherapy and individualized treatment. This educational opportunity will give participants an in depth look at the clinical evidence behind the changes and opportunities for individualized treatment of T2D and in particular those with higher CVD risk to improve patient outcomes.

    Handouts

    Slide Document:   19009L01_6pp(001).pdf


    Slide Document:   19009L01_2pp(001).pdf

    Financial Support By

    Novo Nordisk
  • Nurse

    Review the current treatment guidelines for T2D in patients at risk for cardiovascular events
    Outline the results of cardiovascular outcomes trials of antihyperglycemic therapies in patients with T2D.
    Compare and contrast evidence-based treatment options that optimize glycemic control and reduce cardiovascular events in patients with type 2 diabetes.
    Identify approaches to communicate the potential cardiovascular benefits and risk of various treatment approaches for diabetes to patients and members of the healthcare team.


    Pharmacist

    Review the current treatment guidelines for T2D in patients at risk for cardiovascular events
    Outline the results of cardiovascular outcomes trials of antihyperglycemic therapies in patients with T2D.
    Compare and contrast evidence-based treatment options that optimize glycemic control and reduce cardiovascular events in patients with type 2 diabetes.
    Identify approaches to communicate the potential cardiovascular benefits and risk of various treatment approaches for diabetes to patients and members of the healthcare team.

  • Repeat Presentation

    This is a first run presentation.

    Future Airings

    None

  • Activity Type

    Knowledge

    Universal Activity Number

    Nurse 0798-0000-19-009-L01-N

    Pharmacist 0798-0000-19-009-L01-P

    ACPE PharmCon, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

    PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

    In order to obtain a Statement of Credit, attendees must answer poll questions and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


HARDWARE REQUIREMENTS
Standard Windows/Mac System
iPad or iPhone
Minimum screen resolution: 1024x768
Speakers or headphones
 


SOFTWARE REQUIREMENTS
Microsoft Edge
Internet Explorer 8.0 or higher
Google Chrome
Safari
Firefox 3.0.3 or higher


NETWORK REQUIREMENTS
Broadband Internet Connection:
T1, Hi-speed DSL or Cable
4G cellular connection
 
 

This continuing education activity is held as copyright by PharmCon, Inc. Through this notice, PharmCon, Inc. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.

 

©2015 PharmCon, lnc. All Rights Reserved | Terms & Conditions | Privacy PolicyContinuing Education For Healthcare Professionals
Developed By: ITB, Inc.